StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Consensus shows a sharp YoY earnings decline (EPS $1.65 vs $2.87) and revenue softness ($1.91B vs $1.99B). Historically, CLX has sold off on disappointed guidance or weak margins even with a dividend uptick; the dividend lift may cushion but is unlikely to offset a negative earnings reaction.
What happened, with direct paths to the underlying reporting
Clorox is slated to release Q4 results after the market close on Aug 3, with consensus EPS of $1.65 on $1.91B revenue, a significant YoY decline from $2.87 and $1.99B. The modest dividend hike to $1.25 may cushion sentiment, but investors will focus on margins, cost controls, and any color on volume trends. A disappointing print could weigh on the stock near the $95 level.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.